Aptose Biosciences Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Aptose Biosciences Inc.APTOFJul 2

   Bernd R. Seizinger, insider filing for APTOF

   Bernd R. Seizinger, reporting

2. ROUTINE4Aptose Biosciences Inc.APTOFJul 1

   7 insider filings

   Warren Whitehead, insider filing for APTOF

   Show all 7

   • 4Insider filing for APTOFJul 1
   • 4Insider filing for APTOFJul 1
   • 4Insider filing for APTOFJul 1
   • 4Insider filing for APTOFJul 1
   • 4Insider filing for APTOFJul 1
   • 4Insider filing for APTOFJul 1
   • 4Insider filing for APTOFJul 1

   Warren Whitehead, reporting

3. ROUTINE15-12GAptose Biosciences Inc.APTOFJul 1

   Deregistration notice

4. ROUTINESC 13E3/AAptose Biosciences Inc.APTOFJul 1

   SC 13E3 filing (amended)

5. ROUTINE8-KAptose Biosciences Inc.APTOFJun 15

   Current report

6. ROUTINE8-KAptose Biosciences Inc.APTOFMay 29

   Current report

7. NOTABLE10-QAptose Biosciences Inc.APTOFMay 13

   Quarterly report

8. ROUTINE8-KAptose Biosciences Inc.APTOFMay 13

   Current report

9. ROUTINE8-KAptose Biosciences Inc.APTOFApr 30

   Current report

10. ROUTINESC 13E3/AAptose Biosciences Inc.APTOFApr 1

    SC 13E3 filing (amended)

11. NOTABLE10-KAptose Biosciences Inc.APTOFMar 31

    Annual report

12. ROUTINE8-KAptose Biosciences Inc.APTOFMar 31

    Current report

13. ROUTINE8-KAptose Biosciences Inc.APTOFMar 31

    Current report

14. ROUTINERWAptose Biosciences Inc.APTOFMar 23

    RW filing

15. ROUTINE8-KAptose Biosciences Inc.APTOFMar 23

    Current report

16. ROUTINE8-KAptose Biosciences Inc.APTOFMar 23

    Current report

17. ROUTINE8-KAptose Biosciences Inc.APTOFMar 19

    Current report

18. ROUTINE8-KAptose Biosciences Inc.APTOFFeb 24

    Current report

19. ROUTINESC 13E3/AAptose Biosciences Inc.APTOFFeb 17

    SC 13E3 filing (amended)

20. ROUTINEPRER14AAptose Biosciences Inc.APTOFFeb 17

    PRER14A filing

21. ROUTINESC 13E3/AAptose Biosciences Inc.APTOFFeb 9

    SC 13E3 filing (amended)

22. ROUTINEPRER14AAptose Biosciences Inc.APTOFFeb 9

    PRER14A filing

23. ROUTINEPRER14AAptose Biosciences Inc.APTOFJan 15

    PRER14A filing

24. ROUTINESC 13E3Aptose Biosciences Inc.APTOFJan 15

    SC 13E3 filing

25. ROUTINE8-KAptose Biosciences Inc.APTOFDec 19, 2025

    Current report

26. ROUTINE8-KAptose Biosciences Inc.APTOFDec 8, 2025

    Current report

27. NOTABLEPREM14AAptose Biosciences Inc.APTOFDec 5, 2025

    PREM14A filing

28. ROUTINE8-KAptose Biosciences Inc.APTOFNov 25, 2025

    Current report

29. ROUTINE8-KAptose Biosciences Inc.APTOFNov 19, 2025

    Aptose Biosciences Inc. reported: Regulation FD Disclosure.

    • Item 7.01. Regulation FD Disclosure.
    • Item 9.01. Financial Statements and Exhibits.
30. NOTABLE10-QAptose Biosciences Inc.APTOFNov 13, 2025

    Aptose Biosciences Inc. (APTOF) has filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational progress.

31. ROUTINE8-KAptose Biosciences Inc.APTOFNov 13, 2025

    Aptose Biosciences Inc. (APTOF) announced the appointment of a new Chief Executive Officer, effective immediately. This leadership transition is expected to provide strategic direction and operational expertise to advance the company's pipeline of oncology drug candidates, which…

32. ROUTINE8-KAptose Biosciences Inc.APTOFNov 3, 2025

    Current report

Older filings on EDGAR